Faje, A. T., Lawrence, D., Flaherty, K., Freedman, C., Fadden, R., Rubin, K., . . . Sullivan, R. J. (2018). High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer, 124(18), 3706-3714. https://doi.org/10.1002/cncr.31629
Chicago-Zitierstil (17. Ausg.)Faje, Alexander T., Donald Lawrence, Keith Flaherty, Christine Freedman, Riley Fadden, Krista Rubin, Justine Cohen, und Ryan J. Sullivan. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer 124, no. 18 (2018): 3706-3714. https://doi.org/10.1002/cncr.31629.
MLA-Zitierstil (9. Ausg.)Faje, Alexander T., et al. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer, vol. 124, no. 18, 2018, pp. 3706-3714, https://doi.org/10.1002/cncr.31629.